# Characterization of Cyanocobalamin in Healthy Voluteers After Intranasal and Intramuscual Administration

> **NCT01306123** · PHASE1 · COMPLETED · sponsor: **Swedish Orphan Biovitrum** · enrollment: 16 (actual)

## Conditions studied

- Focus: Bioavailability

## Interventions

- **DRUG:** Nascobal nasal spray (cyanocobalamin, USP)
- **DRUG:** Vitamin B12-ratiopharm N, injection solution

## Key facts

- **NCT ID:** NCT01306123
- **Lead sponsor:** Swedish Orphan Biovitrum
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2014-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01306123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01306123, "Characterization of Cyanocobalamin in Healthy Voluteers After Intranasal and Intramuscual Administration". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01306123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*